A new research has suggested that patients who experience physical or psychological stress - including rigorous exercise - one or two days before a cancer treatment might be unknowingly sabotaging their therapy.
Stress in the body - even physical stress caused by intense exercise - activates a stress-sensitive protein that can spark a series of events that allow cancer cells to survive such treatments as chemotherapy and radiation, according to the research.
Cancer Therapy By Blocking DNA Repair Protein Envisioned
Blocking DNA repair protein could lead to targeted, safer cancer therapy, according to a new American research.
Advertisement
Though the study involved a series of experiments in breast cancer cell cultures, the researchers say the findings are a clear indication that cancer cells have found a way to adapt and resist treatment with the help of this stress-inducible protein.
This cancer cell survival can be traced to the presence of heat shock factor-1, which previous research has linked to stress.
Ohio State University researchers first noticed that this common protein can help heart tissue survive in a toxic environment, leading the scientists to suspect that in cancer, this phenomenon could have serious consequences.
![Chemotherapy-synthetic Compound Combo may Lead to Better Pancreatic Cancer Therapy]( "Chemotherapy-synthetic Compound Combo may Lead to Better Pancreatic Cancer Therapy")
Chemotherapy in combination with a synthetic compound- JP1201 can dramatically reduce human pancreatic cells.
A series of experiments using breast cancer cells showed that a protein activated by the presence of heat shock factor-1 could block the process that kills cancer cells even after the cells' DNA was damaged by radiation. The same was true when the cells were subjected to a common chemotherapy drug.
The researchers hope to develop a drug that could suppress heat shock factor-1 as a supplement to cancer therapy, but in the meantime, they recommend that patients avoid both psychological and physical stress in the days leading up to a cancer treatment.
The study appears online in the journal Molecular Cancer Research.
Source: ANI
Ohio State University researchers first noticed that this common protein can help heart tissue survive in a toxic environment, leading the scientists to suspect that in cancer, this phenomenon could have serious consequences.
Chemotherapy-synthetic Compound Combo may Lead to Better Pancreatic Cancer Therapy
Chemotherapy in combination with a synthetic compound- JP1201 can dramatically reduce human pancreatic cells.
Advertisement
A series of experiments using breast cancer cells showed that a protein activated by the presence of heat shock factor-1 could block the process that kills cancer cells even after the cells' DNA was damaged by radiation. The same was true when the cells were subjected to a common chemotherapy drug.
The researchers hope to develop a drug that could suppress heat shock factor-1 as a supplement to cancer therapy, but in the meantime, they recommend that patients avoid both psychological and physical stress in the days leading up to a cancer treatment.
The study appears online in the journal Molecular Cancer Research.
Source: ANI
Mastectomies Decreased by New Breast Cancer Therapy
Researchers have developed a heat therapy, which when used with chemotherapy destroys large breast cancer tumors, at the University of Oklahoma.
Advertisement
 Molecular Signature to Predict Response to Cancer TherapyA molecular signature that that helps account for the aggressive behavior of a variety of cancers may also help identify patients who are likely to respond to a particular anti-cancer drug | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable